Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BMI | KEYS |
|---|---|---|
| Price | $123.73 | $388.03 |
| Change today | ▼ 0.93% | ▲ 1.00% |
| Market cap | $3.59B | $66.06B |
| Return, 3 months | -14.1% | +22.3% |
| Return, year to date | -28.4% | +91.0% |
| Return, 1 year | -30.0% | +128.2% |
| P/E (TTM) | 29.0 | 53.3 |
| P/B | 5.3 | 10.1 |
| P/E percentile vs own 5y | 3rd | 89th |
| Dividend yield | 1.29% | – |
| Revenue growth (YoY, latest qtr) | – | +36.5% |
| Net profit growth (YoY) | – | +107.9% |
| Gross margin | – | 64.7% |
| Operating margin | – | 20.3% |
| Net margin | – | 19.1% |
| Return on equity | – | 20.6% |
| Analyst target vs. price | +25.2% | +9.0% |
| Analyst buy share | 67% | 91% |
| RSI (14) | 40 | 75 |
| 30-day volatility | 28.0% | 32.8% |
| Max drawdown, 1 year | -39.3% | -20.5% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
